An Overview of Potential Treatment Adverse Effects

EP: 1.Understanding a CLL Diagnosis

EP: 2.Diagnostic Tests in CLL

EP: 3.Goals of Treatment for Patients With CLL

EP: 4.Current First-Line Treatment Options in CLL

EP: 5.Factors That Guide CLL Treatment Decisions

EP: 6.What to Expect from Treatment

EP: 7.Overview of Efficacy and Safety Data for Current CLL Treatment Options

EP: 8.Acalabrutinib-Based Treatment Clinical Trial Updates

EP: 9.Venetoclax-Based Treatment Clinical Trial Updates

EP: 10.Zanubrutinib-Based Treatment Clinical Trial Updates

EP: 11.Ibrutinib-Based Treatment Clinical Trial Updates

EP: 12.Newer Combinations for the Treatment of CLL

EP: 13.What to Know Before Starting Your CLL Treatment

Now Viewing

EP: 14.An Overview of Potential Treatment Adverse Effects

EP: 15.Treatment Decisions in R/R CLL

EP: 16.Shared Decision-Making and Supportive Care in the CLL Treatment Journey

EP: 17.Optimizing Overall Health During CLL Management

EP: 18.Getting the Most From Your CLL Care Team

Video content above is prompted by the following question(s):

• What types of adverse effects may patients encounter with BTK inhibitor therapy? Venetoclax?
• How are these adverse effects typically managed and how does a multidisciplinary team contribute to this process?
• What guidance do you offer to patients to assist them in effective management of potential adverse events?